Helsinki, Finland

Docrates Syopasairaala

Ovarian Epithelial Carcinoma

Squamous Cell Carcinoma of Head and Neck

Adenocarcinoma of Lung

Uterine Cervical Cancer

Triple Negative Breast Cancer

Prostatic Cancer

Cholangiocarcinoma

Non-Small-Cell Lung Carcinoma

Docetaxel

Bemarituzumab

Enzalutamide

Amgen

Pfizer

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

A Phase 3 Study to Compare AMG 510 with Docetaxel in Non Small Cell Lung Cancer (NSCLC) subjects with KRAS p. G12c mutation

Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

Docrates Syopasairaala | Helsinki, Finland

Site insights

Work at this site?

Active trials

Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

Trial sponsors